share_log

Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)

Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)

SEC announcement ·  02/12 19:15
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息